[{"quiz_id": "20251201T041413890Z_grok-4-0709_seed123", "question_id": "20251201T041413890Z_grok-4-0709_seed123-001", "question": "A 58-year-old man with a history of hypertrophic cardiomyopathy presents with recurrent syncope. Genetic testing reveals a mutation in the MYH7 gene. Echocardiography shows asymmetric septal hypertrophy with a left ventricular outflow tract gradient of 80 mmHg at rest. Despite optimal medical therapy with beta-blockers, he continues to experience symptoms. What is the most appropriate next step in management?", "options": ["Implantable cardioverter-defibrillator placement", "Septal myectomy", "Alcohol septal ablation", "Dual-chamber pacing", "Mavacamten initiation"], "answer": "E", "answer_index": 4, "explanation": "Mavacamten is the most appropriate next step as it is a cardiac myosin inhibitor specifically indicated for symptomatic obstructive hypertrophic cardiomyopathy refractory to beta-blockers, targeting the underlying pathophysiology. Septal myectomy and alcohol septal ablation are invasive options reserved for cases not responding to medical therapy, but mavacamten offers a non-invasive alternative with recent evidence supporting its use before procedural interventions. Implantable cardioverter-defibrillator and dual-chamber pacing address arrhythmic risks but not the outflow obstruction directly.", "generator_model": "grok-4-0709", "seed": 123, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": null, "model_outputs": "Batch error (4): The request timed out. Please try again."}, {"quiz_id": "20251201T041413890Z_grok-4-0709_seed123", "question_id": "20251201T041413890Z_grok-4-0709_seed123-002", "question": "A 72-year-old woman with Parkinson's disease develops sudden onset of severe headache, vomiting, and left-sided hemiparesis. MRI reveals a right thalamic hemorrhage with intraventricular extension. She is on carbidopa-levodopa and has a history of orthostatic hypotension. What is the most likely underlying mechanism contributing to this event?", "options": ["Cerebral amyloid angiopathy", "Hypertensive vasculopathy", "Levodopa-induced vasospasm", "Orthostatic hypotension-related watershed infarction", "Dopaminergic therapy-associated coagulopathy"], "answer": "B", "answer_index": 1, "explanation": "Hypertensive vasculopathy is the most likely mechanism, as chronic hypertension in elderly patients with Parkinson's often leads to small vessel disease and thalamic hemorrhages. Cerebral amyloid angiopathy typically affects cortical regions, not deep structures like the thalamus. Levodopa does not directly cause vasospasm or coagulopathy, and while orthostatic hypotension is common, it more often results in ischemic rather than hemorrhagic events.", "generator_model": "grok-4-0709", "seed": 123, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "B", "model_outputs": "This patient presents with a right thalamic hemorrhage. The location of an intracerebral hemorrhage (ICH) is a strong predictor of the underlying etiology.\n\n1.  Location Analysis: Thalamic hemorrhages (along with putaminal, pontine, and cerebellar hemorrhages) are classified as deep or ganglionic hemorrhages. These are classically associated with hypertensive vasculopathy (lipahyalinosis and Charcot-Bouchard microaneurysms) involving small penetrating arteries (e.g., thalamoperforating arteries).\n2.  Cerebral Amyloid Angiopathy (CAA): CAA typically affects cortical and leptomeningeal vessels, leading to lobar hemorrhages (e.g., parietal, occipital), not deep hemorrhages like those in the thalamus.\n3.  Parkinson's Disease and Autonomic Dysfunction: The patient has Parkinson's disease and a history of orthostatic hypotension. In patients with autonomic failure (common in PD), blood pressure regulation is impaired. While they suffer from low blood pressure upon standing (orthostatic hypotension), they frequently experience severe supine hypertension (high blood pressure when lying down). This \"supine hypertension of autonomic failure\" subjects the cerebral vasculature to high pressures, leading to the chronic hypertensive changes (arteriolosclerosis) that predispose to deep ICH.\n4.  Other Options:\n    *   Levodopa does not typically cause vasospasm leading to hemorrhage.\n    *   Orthostatic hypotension leads to hypoperfusion, which would cause watershed ischemic infarctions, not hemorrhage.\n    *   Dopaminergic therapy typically does not cause coagulopathy.\n\nTherefore, despite the history of orthostatic hypotension, the mechanism for a deep thalamic hemorrhage is hypertensive small vessel disease, likely driven by supine hypertension associated with her autonomic dysfunction.\n\nThe answer is (B)"}, {"quiz_id": "20251201T041413890Z_grok-4-0709_seed123", "question_id": "20251201T041413890Z_grok-4-0709_seed123-003", "question": "A 45-year-old man with type 1 diabetes mellitus presents with recurrent hypoglycemia despite dose adjustments. He has a history of autoimmune thyroiditis and vitiligo. Laboratory evaluation shows low morning cortisol and elevated ACTH. What is the most appropriate confirmatory test for the suspected diagnosis?", "options": ["Cosyntropin stimulation test", "Insulin tolerance test", "21-Hydroxylase antibody assay", "Adrenal CT scan", "Metyrapone test"], "answer": "C", "answer_index": 2, "explanation": "21-Hydroxylase antibody assay is the most appropriate confirmatory test for autoimmune adrenalitis in the context of polyglandular autoimmune syndrome type 2, given the patient's other autoimmune conditions. Cosyntropin stimulation test assesses adrenal reserve but does not confirm etiology. Insulin tolerance and metyrapone tests evaluate the hypothalamic-pituitary-adrenal axis but are less specific for autoimmune causes, and adrenal CT is imaging that may show atrophy but not confirm autoimmunity.", "generator_model": "grok-4-0709", "seed": 123, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "C", "model_outputs": "This patient presents with signs and symptoms of Primary Adrenal Insufficiency (Addison's disease), characterized by recurrent hypoglycemia (loss of glucocorticoid counter-regulation), low morning cortisol, and elevated ACTH. His history of type 1 diabetes mellitus, autoimmune thyroiditis, and vitiligo strongly suggests Autoimmune Polyglandular Syndrome Type 2 (APS-2), also known as Schmidt's syndrome.\n\nThe evaluation of suspected primary adrenal insufficiency follows a stepwise approach:\n1.  Establish Cortisol Deficiency: A low morning cortisol (<3–5 µg/dL) in combination with an elevated ACTH level (>2 times the upper limit of normal) is diagnostic for primary adrenal insufficiency. The patient in the vignette has \"low morning cortisol and elevated ACTH,\" which biochemically confirms primary adrenal failure.\n2.  Determine Etiology: Once primary adrenal insufficiency is confirmed biochemically, the goal is to identify the cause. In a patient with known autoimmune diseases (T1DM, thyroiditis, vitiligo), the pre-test probability of autoimmune adrenalitis is extremely high. The most appropriate confirmatory test for the autoimmune etiology is the measurement of 21-hydroxylase antibodies (also known as adrenal cortex antibodies).\n\nAnalysis of Options:\n*   A. Cosyntropin stimulation test: This is the gold standard test to diagnose adrenal insufficiency in cases where morning cortisol levels are equivocal. However, in patients where spontaneous morning cortisol is clearly low and ACTH is elevated, the diagnosis of primary adrenal insufficiency is already established. The adrenal glands are already being maximally stimulated by endogenous ACTH without producing cortisol; adding exogenous ACTH (cosyntropin) provides no additional diagnostic information and is considered unnecessary by current Endocrine Society guidelines.\n*   B. Insulin tolerance test (ITT): This test is used to assess the integrity of the hypothalamic-pituitary-adrenal (HPA) axis (secondary adrenal insufficiency). It is contraindicated in this patient because he already suffers from recurrent hypoglycemia, and it carries significant risk. Furthermore, the elevated ACTH rules out secondary adrenal insufficiency.\n*   C. 21-Hydroxylase antibody assay: Positive antibodies confirm the diagnosis of autoimmune adrenalitis (Addison's disease). This is the correct next step to confirm the specific suspected diagnosis in a patient with established primary insufficiency and a strong autoimmune history.\n*   D. Adrenal CT scan: Imaging is indicated if 21-hydroxylase antibodies are negative or if there is suspicion of other pathologies like tuberculosis, hemorrhage, or metastasis. It is not the first-line confirmatory test for autoimmune adrenalitis.\n*   E. Metyrapone test: This is an older test used to assess pituitary ACTH reserve (secondary AI) and is rarely used today. It is not appropriate for primary adrenal insufficiency.\n\nThe answer is (C)"}, {"quiz_id": "20251201T041413890Z_grok-4-0709_seed123", "question_id": "20251201T041413890Z_grok-4-0709_seed123-004", "question": "A 60-year-old smoker with COPD presents with progressive dyspnea and hemoptysis. CT chest reveals a 2 cm spiculated nodule in the right upper lobe with mediastinal lymphadenopathy. Bronchoscopy with biopsy confirms squamous cell carcinoma. PET-CT shows no distant metastases. What is the most appropriate initial management?", "options": ["Stereotactic body radiotherapy", "Surgical lobectomy with lymph node dissection", "Concurrent chemoradiotherapy", "Immune checkpoint inhibitor monotherapy", "Epidermal growth factor receptor tyrosine kinase inhibitor"], "answer": "B", "answer_index": 1, "explanation": "Surgical lobectomy with lymph node dissection is the most appropriate for stage I squamous cell lung cancer in a patient with adequate pulmonary reserve, offering the best chance for cure. Stereotactic body radiotherapy is an alternative for non-surgical candidates, but this patient has no contraindications mentioned. Chemoradiotherapy and targeted therapies are for more advanced stages or specific molecular profiles not indicated here.", "generator_model": "grok-4-0709", "seed": 123, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "C", "model_outputs": "This patient presents with a 2 cm right upper lobe lung nodule and mediastinal lymphadenopathy, with biopsy confirming squamous cell carcinoma. The staging workup (CT and PET-CT) indicates the presence of mediastinal lymphadenopathy without distant metastases.\n\n1.  Staging: The tumor is likely T1 (based on size 2 cm). However, the presence of mediastinal lymphadenopathy places the disease at least in Stage IIIA (if ipsilateral mediastinal nodes, N2) or Stage IIIB (if contralateral mediastinal nodes, N3).\n2.  Management of Stage III NSCLC:\n    *   Upfront Surgery (Option B) is generally not indicated for patients with clinically apparent mediastinal nodal involvement (cN2 or cN3) identified on imaging. The standard of care for unresectable (or borderline resectable) locally advanced NSCLC is definitive concurrent chemoradiotherapy.\n    *   SBRT (Option A) is indicated for early-stage (Stage I/II), node-negative disease in patients who are medically inoperable. It is not appropriate for node-positive disease.\n    *   Immunotherapy (Option D) generally follows chemoradiotherapy as consolidation (e.g., durvalumab) in Stage III disease or is used in Stage IV disease. It is not the initial monotherapy for this stage.\n    *   EGFR TKIs (Option E) are used for patients with EGFR mutations. These mutations are rare in squamous cell carcinoma (more common in adenocarcinoma), and TKI therapy is typically reserved for advanced (Stage IV) or adjuvant settings, not as initial definitive therapy for locally advanced disease without mutation confirmation. Also, TKIs are generally not superior to chemoradiation in locally advanced disease for cure.\n\nTherefore, the most appropriate initial management for a patient with good performance status and locally advanced (Stage III) non-small cell lung cancer characterized by mediastinal node involvement is concurrent chemoradiotherapy.\n\nThe answer is (C)"}, {"quiz_id": "20251201T041413890Z_grok-4-0709_seed123", "question_id": "20251201T041413890Z_grok-4-0709_seed123-005", "question": "A 35-year-old woman in the emergency department presents with chest pain, palpitations, and diaphoresis after using cocaine. ECG shows ST-segment elevation in leads V2-V4. Troponin is elevated. Coronary angiography reveals a thrombus in the left anterior descending artery with no underlying atherosclerosis. What is the most appropriate immediate management?", "options": ["Intracoronary thrombolysis", "Percutaneous coronary intervention with stenting", "Systemic anticoagulation with heparin", "Glycoprotein IIb/IIIa inhibitor infusion", "Aspiration thrombectomy"], "answer": "E", "answer_index": 4, "explanation": "Aspiration thrombectomy is the most appropriate for cocaine-induced myocardial infarction due to vasospasm and thrombus without atherosclerosis, allowing removal of the clot while minimizing vessel trauma. Stenting is unnecessary without plaque, and thrombolysis carries bleeding risks. Anticoagulation and glycoprotein inhibitors are adjunctive but not primary interventions for isolated thrombus.", "generator_model": "grok-4-0709", "seed": 123, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "E", "model_outputs": "In the context of a cocaine-induced myocardial infarction where angiography reveals a thrombus but no underlying atherosclerosis, the goal of management is to remove the obstruction and restore blood flow without placing a permanent stent in an otherwise healthy vessel. Stenting (Option B) is generally avoided in vessels without atherosclerotic lesions because of the risk of stent malapposition, thrombosis, and the commitment to long-term dual antiplatelet therapy in a patient population where compliance may be a concern.\n\nAspiration thrombectomy (Option E) allows for the mechanical removal of the thrombus. While routine aspiration thrombectomy is no longer recommended for all STEMI patients (following the TOTAL trial), it remains a reasonable and often preferred strategy for patients with a large thrombus burden and no underlying atherosclerotic stenosis to avoid the placement of a stent.\n\nIntracoronary thrombolysis (Option A) is rarely used in current practice. Systemic anticoagulation (Option C) and Glycoprotein IIb/IIIa inhibitors (Option D) are important adjunctive therapies but do not mechanically resolve the immediate obstruction as effectively as thrombectomy in this specific angiographic scenario.\n\nThe answer is (E)"}, {"quiz_id": "20251201T041413890Z_grok-4-0709_seed123", "question_id": "20251201T041413890Z_grok-4-0709_seed123-006", "question": "A 68-year-old man with atrial fibrillation on anticoagulation develops acute right-sided weakness. CT head shows no hemorrhage, and MRI confirms acute ischemic stroke in the left middle cerebral artery territory. He is within 4.5 hours of symptom onset. What is the most critical factor determining eligibility for intravenous thrombolysis?", "options": ["International normalized ratio value", "Time since last anticoagulant dose", "Presence of atrial fibrillation", "Stroke severity on NIHSS scale", "Reversal agent availability"], "answer": "A", "answer_index": 0, "explanation": "The international normalized ratio value is the most critical, as thrombolysis is contraindicated if INR >1.7 in patients on vitamin K antagonists to avoid hemorrhagic complications. Time since last dose affects coagulopathy but INR directly measures it. Atrial fibrillation and stroke severity influence overall management but not thrombolysis eligibility directly, and reversal agents are for bleeding, not pre-thrombolysis.", "generator_model": "grok-4-0709", "seed": 123, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": null, "model_outputs": "Batch error (4): The request timed out. Please try again."}, {"quiz_id": "20251201T041413890Z_grok-4-0709_seed123", "question_id": "20251201T041413890Z_grok-4-0709_seed123-007", "question": "A 52-year-old woman with acromegaly undergoes transsphenoidal surgery. Postoperatively, she develops polyuria with urine output exceeding 300 mL/hour. Serum sodium is 148 mEq/L, and urine specific gravity is 1.002. What is the most appropriate initial pharmacologic intervention?", "options": ["Desmopressin acetate", "Hydrochlorothiazide", "Demeclocycline", "Tolvaptan", "Conivaptan"], "answer": "A", "answer_index": 0, "explanation": "Desmopressin acetate is the most appropriate for central diabetes insipidus following pituitary surgery, replacing deficient antidiuretic hormone to concentrate urine. Hydrochlorothiazide is used for nephrogenic diabetes insipidus, not central. Demeclocycline and vasopressin antagonists like tolvaptan or conivaptan are for syndrome of inappropriate antidiuretic hormone, which would worsen hypernatremia here.", "generator_model": "grok-4-0709", "seed": 123, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": null, "model_outputs": "Batch error (4): The request timed out. Please try again."}, {"quiz_id": "20251201T041413890Z_grok-4-0709_seed123", "question_id": "20251201T041413890Z_grok-4-0709_seed123-008", "question": "A 55-year-old man with idiopathic pulmonary fibrosis presents with acute worsening dyspnea. High-resolution CT shows new ground-glass opacities superimposed on fibrosis. Bronchoalveolar lavage reveals neutrophilia without infection. What is the most appropriate therapeutic approach?", "options": ["High-dose systemic corticosteroids", "Azathioprine addition to regimen", "Pirfenidone dose escalation", "Nintedanib initiation", "Lung transplantation evaluation"], "answer": "A", "answer_index": 0, "explanation": "High-dose systemic corticosteroids are the most appropriate for acute exacerbation of idiopathic pulmonary fibrosis, aiming to suppress inflammation despite limited evidence. Azathioprine is contraindicated due to increased mortality risk. Pirfenidone and nintedanib are antifibrotics for stable disease, not acute flares, and transplantation is for end-stage but not immediate management.", "generator_model": "grok-4-0709", "seed": 123, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "A", "model_outputs": "This patient presents with signs and symptoms consistent with an acute exacerbation of idiopathic pulmonary fibrosis (AE-IPF). This is defined by an acute worsening of dyspnea (usually within 30 days), new bilateral ground-glass opacities superimposed on a background of usual interstitial pneumonia (UIP) pattern on HRCT, and the exclusion of alternative causes such as heart failure or infection (confirmed here by the absence of infection in the bronchoalveolar lavage).\n\nThe management of AE-IPF is challenging and carries a high mortality rate. Based on international guidelines (ATS/ERS/JRS/ALAT):\n\n1.  High-dose systemic corticosteroids (Option A) are the most commonly recommended pharmacological treatment. While the evidence supporting their use is low-quality and the recommendation is \"weak\" or conditional, they are the standard of care in an attempt to suppress the acute alveolar injury and inflammation suggested by the ground-glass opacities and BAL neutrophilia.\n2.  Azathioprine (Option B) is generally contraindicated in IPF based on the PANTHER-IPF trial, which showed increased mortality and hospitalization when combined with prednisone and N-acetylcysteine.\n3.  Pirfenidone and Nintedanib (Options C and D) are antifibrotic agents used for the chronic maintenance treatment of IPF to slow disease progression. While they may reduce the risk of future exacerbations, initiating or escalating the dose of these drugs is not the primary rescue therapy for an active acute exacerbation.\n4.  Lung transplantation evaluation (Option E) is a crucial step for long-term survival in eligible candidates, particularly given the poor prognosis of AE-IPF. However, it is a process for disposition rather than an immediate therapeutic intervention to stabilize the patient's acute respiratory failure. High-dose corticosteroids are the immediate therapeutic action taken.\n\nTherefore, high-dose systemic corticosteroids are the most appropriate immediate therapeutic approach among the choices provided.\n\nThe answer is (A)"}, {"quiz_id": "20251201T041413890Z_grok-4-0709_seed123", "question_id": "20251201T041413890Z_grok-4-0709_seed123-009", "question": "A 28-year-old man in the emergency department after a motor vehicle collision has hypotension, tachycardia, and abdominal distension. FAST exam shows free fluid in the abdomen. He is taken to the operating room for exploratory laparotomy, revealing a splenic laceration. What is the most appropriate intraoperative management for a hemodynamically unstable patient?", "options": ["Splenic artery embolization", "Partial splenectomy", "Splenorrhaphy with hemostatic agents", "Total splenectomy", "Non-operative management with observation"], "answer": "D", "answer_index": 3, "explanation": "Total splenectomy is the most appropriate for hemodynamically unstable patients with high-grade splenic injury to rapidly control bleeding and stabilize the patient. Embolization and non-operative management are for stable patients. Partial splenectomy or splenorrhaphy preserve splenic function but are time-consuming and risky in instability.", "generator_model": "grok-4-0709", "seed": 123, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "D", "model_outputs": "Based on the clinical presentation, the patient is hemodynamically unstable (hypotension, tachycardia) following blunt abdominal trauma. He has already been taken to the operating room for an exploratory laparotomy due to the instability and positive FAST exam.\n\nThe primary goal in a hemodynamically unstable trauma patient is immediate hemorrhage control (\"damage control\").\n\n*   Option A (Splenic artery embolization) is typically performed in Interventional Radiology for hemodynamically stable patients who have evidence of active bleeding (contrast blush) on CT scan. It is not the treatment of choice for an unstable patient already in the OR.\n*   Option B (Partial splenectomy) and Option C (Splenorrhaphy) are splenic salvage procedures. These are time-consuming and require a stable patient. Attempting to save the spleen in an unstable patient risks prolonged bleeding and death.\n*   Option E (Non-operative management) is the standard of care for stable patients with blunt splenic injury. This patient is unstable and has already required a laparotomy, making this option incorrect.\n*   Option D (Total splenectomy) is the most appropriate management for a hemodynamically unstable patient with a shattered or bleeding spleen found at laparotomy. It provides the most rapid and definitive control of hemorrhage, which is the priority over splenic preservation in this life-threatening scenario.\n\nThe answer is (D)"}, {"quiz_id": "20251201T041413890Z_grok-4-0709_seed123", "question_id": "20251201T041413890Z_grok-4-0709_seed123-010", "question": "A 65-year-old woman with rheumatoid arthritis develops shortness of breath. Echocardiography reveals severe mitral regurgitation with a flail leaflet. She has preserved left ventricular function but elevated pulmonary pressures. Coronary angiography is normal. What is the most appropriate intervention?", "options": ["Mitral valve repair", "Mitral valve replacement with bioprosthesis", "Transcatheter edge-to-edge repair", "Medical management with afterload reduction", "Cardiac resynchronization therapy"], "answer": "A", "answer_index": 0, "explanation": "Mitral valve repair is the most appropriate for severe primary mitral regurgitation due to flail leaflet in a surgical candidate, offering better durability and preservation of ventricular function compared to replacement. Transcatheter repair is for high-risk patients or functional regurgitation. Medical management and resynchronization do not address the structural defect.", "generator_model": "grok-4-0709", "seed": 123, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "A", "model_outputs": "Analysis of the Clinical Scenario:\n\n1.  Patient & Condition: The patient is a 65-year-old woman with symptomatic (shortness of breath) severe mitral regurgitation (MR).\n2.  Etiology: The echocardiogram shows a \"flail leaflet.\" A flail leaflet is characteristic of primary (degenerative) MR, typically resulting from ruptured chordae tendineae.\n3.  Indication for Intervention: According to ACC/AHA guidelines, symptomatic patients with severe primary MR and preserved Left Ventricular Ejection Fraction (LVEF > 30%) have a Class I indication for surgical intervention. This patient is symptomatic and has elevated pulmonary pressures, reinforcing the need for correction rather than just medical management.\n4.  Medical Management (D): Medical therapy (diuretics, afterload reduction) is used for symptom relief or stabilization but does not correct the underlying mechanical problem in primary MR and is not the definitive treatment for a surgical candidate.\n5.  CRT (E): Cardiac Resynchronization Therapy is indicated for heart failure with reduced ejection fraction (usually <35%) and wide QRS complex. This patient has preserved LV function.\n6.  Surgical Repair vs. Replacement (A vs. B):\n    *   Mitral Valve Repair (A): This is the gold standard and preferred treatment for primary MR when the anatomy allows. It is associated with lower operative mortality, better preservation of LV function, and better long-term survival compared to replacement. A \"flail leaflet\" (especially of the posterior leaflet) is a classic anatomic presentation that is highly amenable to successful repair.\n    *   Mitral Valve Replacement (B): Replacement is reserved for patients in whom repair is not feasible or typically for those with severe rheumatic changes (calcification/retraction) that preclude repair. While Rheumatoid Arthritis (RA) can cause valvular nodules or thickening, the specific finding of a \"flail leaflet\" suggests a mechanical failure (chordal rupture) that is best treated with repair. RA is not a contraindication to repair unless the valve tissue is destroyed, which is not stated here.\n7.  Transcatheter Edge-to-Edge Repair (C): TEER (e.g., MitraClip) is FDA approved for primary MR in patients who are at prohibitive or high surgical risk. This patient is 65 years old with normal coronary angiography and preserved LV function, suggesting she is a standard surgical candidate. Therefore, surgical repair is superior to TEER in terms of efficacy (reduction of MR).\n\nConclusion:\nThe patient has symptomatic severe primary mitral regurgitation due to a flail leaflet and is a candidate for surgery. The guidelines strongly recommend mitral valve repair over replacement or transcatheter interventions for patients with this anatomy who are not at high surgical risk.\n\nThe answer is (A)"}]